Endoscopic Findings in Mantle Cell Lymphoma with Gastrointestinal Tract Involvement
Authors:
- Hyun Wook JungHJHyun Wook Jung
- Ki Joo KangKKKi Joo Kang
- Byung-Hoon MinBMByung-Hoon Min
- Jun Haeng LeeJLJun Haeng Lee
- Dong Kyung ChangDCDong Kyung Chang
- Young Ho KimYKYoung Ho Kim
- Hee Jung SonHSHee Jung Son
- Poong-Lyul RheePRPoong-Lyul Rhee
- Jae J. KimJKJae J. Kim
- Jong Chul RheeJRJong Chul Rhee
- Seok Jin KimSKSeok Jin Kim
- 12 January 2012
- journal article
- case report
- Published by S. Karger AG in Acta Haematologica
- Vol. 127 (3) , 129-134
Abstract
Background and Aims: Mantle cell lymphoma (MCL) of the gastrointestinal (GI) tract is a rare disease with a poor prognosis. The aim of this study was to determine clinical and endoscopic characteristics of patients with GI MCL. Methods: Clinical features of 19 patients with GI MCL were reviewed along with the endoscopic findings on 27 anatomical lesions. Results: The initial presenting symptoms were abdominal pain (n = 7, 36.8%), GI tract bleeding (n = 5, 26.3%), dyspnea (n = 2, 10.5%), indigestion (n = 1, 5.3%), diarrhea (n = 1, 5.3%), cervical lymphadenopathy (n = 1, 5.3%), tonsilar mass (n = 1, 5.3%), and no symptoms (n = 1, 5.3%). On endoscopy, in 19 patients with 27 lesions, the anatomic locations of the lesions were: stomach, n = 2 (10.5%); stomach and colon, n = 7 (36.8%); terminal ileum and colon, n = 1 (5.3%); colon, n = 9 (47.4%). There was 1 fungating case (3.7%), 4 ulcerative cases (14.8%), 9 infiltrative cases (33.3%), and 13 polypoid cases (48.1%). Conclusions: The endoscopic findings in GI MCL are variable, with common presenting manifestations of abdominal pain and GI bleeding.Keywords
This publication has 17 references indexed in Scilit:
- Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphomaAnnals of Oncology, 2010
- Nonpolypoid Intestinal Mantle Cell Lymphoma Resembling MALT Lymphoma with Successful Response to RituximabSouthern Medical Journal, 2008
- Therapy of Mantle Cell Lymphoma: Current Standards and Future StrategiesHematology/Oncology Clinics of North America, 2008
- Primary Colon Lymphoma in Korea: A KASID (Korean Association for the Study of Intestinal Diseases) StudyDigestive Diseases and Sciences, 2005
- High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and CytarabineJournal of Clinical Oncology, 2005
- Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL NetworkBlood, 2005
- Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tractJournal of Gastroenterology, 2004
- Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphomaCancer, 2003
- The World Health Organization Classification of Neoplasms of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting – Airlie House, Virginia, November, 1997The Hematology Journal, 2000
- Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular DataAmerican Journal of Surgical Pathology, 1992